Augustine Asset Management
REGN icon

Augustine Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Augustine Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.17M Sell
6,820
-64
-0.9% -$48.4K 1.12% 23
2026
Q2 		$4.29M Buy
6,884
+2,405
+54% +$1.64M 0.87% 24
2026
Q1 		$3.46M Buy
4,479
+8
+0.2% +$6.12K 0.78% 26
2025
Q4 		$3.45M Sell
4,471
-6
-0.1% -$4.08K 0.69% 24
2025
Q3 		$2.52M Sell
4,477
-31
-0.7% -$17.5K 0.51% 30
2025
Q2 		$2.37M Buy
4,508
+39
+0.9% +$21.8K 0.63% 27
2025
Q1 		$2.83M Sell
4,469
-5
-0.1% -$3.44K 0.83% 25
2024
Q4 		$3.19M Sell
4,474
-68
-1% -$57.1K 0.84% 22
2024
Q3 		$4.77M Sell
4,542
-14
-0.3% -$15.6K 1.67% 15
2024
Q2 		$4.79M Buy
4,556
+21
+0.5% +$20.4K 1.85% 13
2024
Q1 		$4.36M Sell
4,535
-11
-0.2% -$10.5K 1.82% 13
2023
Q4 		$3.99M Buy
4,546
+214
+5% +$176K 1.77% 17
2023
Q3 		$3.57M Sell
4,332
-136
-3% -$107K 1.65% 14
2023
Q2 		$3.21M Sell
4,468
-10
-0.2% -$7.71K 1.48% 17
2023
Q1 		$3.68M Sell
4,478
-26
-0.6% -$19.6K 1.82% 15
2022
Q4 		$3.25M Sell
4,504
-93
-2% -$68.6K 1.8% 17
2022
Q3 		$3.17M Buy
4,597
+4
+0.1% +$2.52K 2.08% 15
2022
Q2 		$2.72M Sell
4,593
-372
-7% -$242K 1.67% 20
2022
Q1 		$3.47M Sell
4,965
-11
-0.2% -$6.96K 1.74% 18
2021
Q4 		$3.14M Buy
4,976
+41
+0.8% +$25.2K 1.54% 22
2021
Q3 		$2.99M Sell
4,935
-107
-2% -$66.4K 1.59% 22
2021
Q2 		$2.82M Sell
5,042
-211
-4% -$107K 1.45% 23
2021
Q1 		$2.48M Buy
5,253
+39
+0.7% +$19K 1.31% 26
2020
Q4 		$2.52M Sell
5,214
-14
-0.3% -$7.56K 1.31% 27
2020
Q3 		$2.93M Sell
5,228
-356
-6% -$216K 1.72% 20
2020
Q2 		$3.48M Buy
5,584
+2,218
+66% +$1.26M 2.1% 16
2020
Q1 		$1.64M Buy
+3,366
New +$1.39M 1.17% 26

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
LMCG Investments
LMCG Investments Boston, Massachusetts $1.86B AUM 40.01% 1-Year Est. Return

Augustine Asset Management's REGN Position: Q3 2026 in Review

Augustine Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.93% in Q3 2026, selling an estimated $48.4K and leaving 6,820 shares worth $5.17M. The position accounts for 1.12% of the portfolio, ranked #23.

Augustine Asset Management first reported a position in REGN in Q1 2020 and has held it in 27 quarters since. 333 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Augustine Asset Management held 6,820 shares of Regeneron Pharmaceuticals worth $5.17M as of Q3 2026.
  • Augustine Asset Management sold 64 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $48.4K.
  • Regeneron Pharmaceuticals made up 1.12% of Augustine Asset Management's portfolio in Q3 2026, its #23 holding.
  • Augustine Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
  • 333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Augustine Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.